A series of private discussions between senior No 10 advisers, pharmaceutical companies and private healthcare providers have taken place about ideas for transforming the NHS. The plans include lifting safeguards blocking access to patient data. A freedom of information request revealed discussions took place after Boris Johnson appointed a taskforce to generate ideas for cutting red tape after Brexit. Those in attendance included GlaxoSmithKline, Johnson & Johnson, drug company lobbyists and William Warr, Mr Johnson’s chief health adviser. Campaigners for transparency and patient confidentiality have expressed their concerns over the suggestions, which, if implemented, they claim could lower standards and weaken patient protections.
What is this page?
You are reading a summary article on the Privacy Newsfeed, a free resource for DPOs and other professionals with privacy or data protection responsibilities helping them stay informed of industry news all in one place. The information here is a brief snippet relating to a single piece of original content or several articles about a common topic or thread. The main contributor is listed in the top left-hand corner, just beneath the article title.
The Privacy Newsfeed monitors over 300 global publications, of which more than 5,750 summary articles have been posted to the online archive dating back to the beginning of 2020. A weekly roundup is available by email every Friday.
